CEO: | Phil L'Huillier |
CFO: | Sath Nirmalananthan |
Chief Scientific Officer: | Lindy Durrant |
Deputy Chairman: | Susan Clement Davies |
Non-Executive Chairman: | Jean-Michel Cosséry |
Non-Executive Dir: | Ursula Ney, Florian Reinaud, Martin Diggle |
Address: | Bellhouse Building, Sanders Road, Oxford Science Park, Oxford, United Kingdom , OX4 4GD |
Website: | http://www.scancell.co.uk/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00B63D3314 |
Currency | UK Pounds |
Share Price | 9.75p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 16.50 |
52 Week Low | 7.50 |
Volume | 306,544 |
Shares Issued | 1,037.78m |
Market Cap | £101.18m |
Beta | 0.00 |
Value | ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
14:26 | 50,000 @ 9.68p |
14:09 | 82,000 @ 9.59p |
13:06 | 2,080 @ 9.59p |
12:57 | 13,897 @ 9.59p |
11:25 | 2,245 @ 9.59p |
CFO | Sath Nirmalananthan |
CEO | Phil L'Huillier |
You are here: research